Structured evidence table for Chlorogenic Acid Cardiometabolic Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Chlorogenic Acid Cardiometabolic Randomized Trial | Pre-obesity is a condition that predisposes to the risk of developing obesity, cardiovascular diseases (CVD), and diabetes. | 2 | Terzo S (2023) | A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study. |
| Chlorogenic Acid Cardiometabolic Randomized Trial | After six months of treatment Altilix® significantly reduced body weight, glycemic, and lipid parameters (total cholesterol, triglycerides, LDL-cholesterol) and improved hepatic functionality, CIMT, and FMD. | 2 | Terzo S (2023) | A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study. |
| Chlorogenic Acid Cardiometabolic Randomized Trial | In conclusion, these results confirm that Altilix® supplementation has a significant effect on cardiometabolic parameters not only in obese subjects but also in pre-obesity subjects. | 2 | Terzo S (2023) | A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study. |
| Chlorogenic Acid Cardiometabolic Randomized Trial | Our previous study demonstrated that a Cynara cardunculus (L.) based nutraceutical named Altilix® (Bionap, Italy), containing chlorogenic acid and luteolin extracts, was able to improve several hepatic and cardio-metabolic parameters. | 2 | Terzo S (2023) | A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study. |
| Chlorogenic Acid Cardiometabolic Randomized Trial | It also significantly improved thermotolerance and resistance to oxidative stress in C . | 4 | Todorova MN (2026) | <i>Echinophora tenuifolia</i> L. subsp. <i>sibthorpiana</i> Modulates Stress Response and Mitochondrial Quality Under Glucose Stress in <i>Caenorhabditis elegans</i>. |
| Chlorogenic Acid Cardiometabolic Randomized Trial | Additionally, in a glucose-induced obesity model, the extract reduced lipid accumulation and triglyceride levels and restored glucose-impaired mitochondrial membrane potential. | 4 | Todorova MN (2026) | <i>Echinophora tenuifolia</i> L. subsp. <i>sibthorpiana</i> Modulates Stress Response and Mitochondrial Quality Under Glucose Stress in <i>Caenorhabditis elegans</i>. |
| Chlorogenic Acid Cardiometabolic Randomized Trial | tenuifolia ), Apiaceae, is a traditional medicinal and culinary plant, yet its phytochemical composition and biological activity have not been fully investigated. | 4 | Todorova MN (2026) | <i>Echinophora tenuifolia</i> L. subsp. <i>sibthorpiana</i> Modulates Stress Response and Mitochondrial Quality Under Glucose Stress in <i>Caenorhabditis elegans</i>. |
| Chlorogenic Acid Cardiometabolic Randomized Trial | tenuifolia aerial parts extract and to assess its effects on healthspan and metabolic regulation in Caenorhabditis elegans ( C . | 4 | Todorova MN (2026) | <i>Echinophora tenuifolia</i> L. subsp. <i>sibthorpiana</i> Modulates Stress Response and Mitochondrial Quality Under Glucose Stress in <i>Caenorhabditis elegans</i>. |
Source documents